X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs BIOCON - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA BIOCON SANOFI INDIA/
BIOCON
 
P/E (TTM) x 36.2 16.7 216.5% View Chart
P/BV x 6.3 2.6 245.1% View Chart
Dividend Yield % 1.4 0.4 307.2%  

Financials

 SANOFI INDIA   BIOCON
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
BIOCON
Mar-18
SANOFI INDIA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs6,8401,188 575.8%   
Low Rs4,630305 1,518.0%   
Sales per share (Unadj.) Rs1,203.168.7 1,750.7%  
Earnings per share (Unadj.) Rs165.37.6 2,188.4%  
Cash flow per share (Unadj.) Rs209.914.0 1,502.2%  
Dividends per share (Unadj.) Rs84.001.00 8,400.0%  
Dividend yield (eoy) %1.50.1 1,093.4%  
Book value per share (Unadj.) Rs963.686.3 1,116.0%  
Shares outstanding (eoy) m23.03600.00 3.8%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x4.810.9 43.9%   
Avg P/E ratio x34.798.9 35.1%  
P/CF ratio (eoy) x27.353.4 51.1%  
Price / Book Value ratio x6.08.6 68.8%  
Dividend payout %50.813.2 383.8%   
Avg Mkt Cap Rs m132,078447,900 29.5%   
No. of employees `0003.36.1 53.7%   
Total wages/salary Rs m4,0689,311 43.7%   
Avg. sales/employee Rs Th8,393.86,705.8 125.2%   
Avg. wages/employee Rs Th1,232.41,514.2 81.4%   
Avg. net profit/employee Rs Th1,153.0736.9 156.5%   
INCOME DATA
Net Sales Rs m27,70841,234 67.2%  
Other income Rs m8972,062 43.5%   
Total revenues Rs m28,60543,296 66.1%   
Gross profit Rs m6,2358,291 75.2%  
Depreciation Rs m1,0273,851 26.7%   
Interest Rs m7615 1.1%   
Profit before tax Rs m6,0985,887 103.6%   
Minority Interest Rs m0213 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2921,569 146.1%   
Profit after tax Rs m3,8064,531 84.0%  
Gross profit margin %22.520.1 111.9%  
Effective tax rate %37.626.7 141.0%   
Net profit margin %13.711.0 125.0%  
BALANCE SHEET DATA
Current assets Rs m15,92241,486 38.4%   
Current liabilities Rs m6,23521,413 29.1%   
Net working cap to sales %35.048.7 71.8%  
Current ratio x2.61.9 131.8%  
Inventory Days Days6464 99.5%  
Debtors Days Days2194 22.2%  
Net fixed assets Rs m7,53950,661 14.9%   
Share capital Rs m2303,000 7.7%   
"Free" reserves Rs m21,96248,808 45.0%   
Net worth Rs m22,19251,808 42.8%   
Long term debt Rs m017,898 0.0%   
Total assets Rs m29,83999,897 29.9%  
Interest coverage x872.110.6 8,249.3%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.90.4 225.0%   
Return on assets %12.85.2 248.1%  
Return on equity %17.28.7 196.1%  
Return on capital %27.59.6 285.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,58712,058 62.9%   
Fx outflow Rs m7,1457,348 97.2%   
Net fx Rs m4424,710 9.4%   
CASH FLOW
From Operations Rs m3,7396,621 56.5%  
From Investments Rs m-731-6,840 10.7%  
From Financial Activity Rs m-1,972-2,397 82.3%  
Net Cashflow Rs m1,036-2,612 -39.7%  

Share Holding

Indian Promoters % 0.0 40.4 -  
Foreign collaborators % 60.4 20.6 293.2%  
Indian inst/Mut Fund % 14.4 8.4 171.4%  
FIIs % 14.6 10.7 136.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 19.9 52.8%  
Shareholders   15,184 109,995 13.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   GLENMARK PHARMA  FULFORD INDIA  PROCTER & GAMBLE HEALTH  DIVIS LABORATORIES  UNICHEM LAB  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 267 Points Lower; Metal and Capital Goods Stocks Witness Huge Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 267 points (down 0.7%).

Related Views on News

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

BIOCON Announces Quarterly Results (1QFY20); Net Profit Down 11.5% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, BIOCON has posted a net profit of Rs 1 bn (down 11.5% YoY). Sales on the other hand came in at Rs 5 bn (down 57.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

More Views on News

Most Popular

The Perfect Stock in the Rebirth of India(The 5 Minute Wrapup)

Aug 8, 2019

This debt-free, well-managed company is all set to soar.

This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Super investor Pulak Prasad is Buying Stocks Big Time...and You Should Too(The 5 Minute Wrapup)

Aug 9, 2019

Here's why the relentless correction in the Indian stock markets has not unnerved the big investors.

Smallcaps that Will Outperform in the Market Rebound(Profit Hunter)

Aug 12, 2019

Only These Smallcaps Will Give Historic Returns in the Future.

Qatar is Rearing Cows...this is Good News for India

Aug 9, 2019

Qatar has turned around after the Saudi embargo. This is good news for India.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Aug 21, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - CIPLA COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS